Unlocking Intracellular Targets Through Synapse-Optimised T cell Engagers

  • Discover and validate novel MHC presented targets
  • Optimize, in parallel, our TCR-Ab binders, our anti-CD3, and our format for optimal synapse formation and therapeutic window